ArticleMolecular and clinical oncology2016

CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer.

Ming Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.